Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
boston blog main
deals
5
×
life sciences
national blog main
sanofi
5
×
biotech
boston top stories
clinical trials
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
alnylam pharmaceuticals
amgen
boston
cancer
fda
investing
ipo
novartis
startups
venture capital
abbvie
akouos
alirocumab
allergan
allosteric
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
atlas venture
atopic dermatitis
autoimmune disorders
biogen
biontech
bluerock therapeutics
boehringer ingelheim
boulder/denver blog main
What
medicines
5
×
deal
new
bio
cancer
drug
ipo
molecules
targets
years
acquire
acquisitions
address
adds
ago
agreed
allosteric
announced
bets
billion
brings
cash
ceo
cholesterol
clinic
collabs
comes
companies
company
compound
covid
cut
daniel
date
despite
disease
effective
elusive
enticed
evidence
Language
unset
Current search:
medicines
×
photo
×
sanofi
×
deals
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
